Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Mitral valve Stories

2010-09-13 12:20:55

David H. Adams, MD, Marie-Jos©e and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery at The Mount Sinai Medical Center, has performed the first implantation of the Medtronic Tri-Ad Semi-Flexible Tricuspid Annuloplasty Ring in the United States. Dr. Adams invented the ring, which was recently approved by the Food and Drug Administration. The tricuspid valve lies between the right atrium and right ventricle of the heart. Tricuspid valve regurgitation...

2010-08-18 05:00:00

KIRKLAND, Wash., Aug. 18 /PRNewswire/ -- Cardiac Dimensions, an early stage company focused on the development of minimally invasive devices for the treatment of mitral valve disease and congestive heart failure, announced today that the 12-month follow-up results from the TITAN(TM) trial of the Company's CARILLON® Mitral Contour System will be presented at the European Society of Cardiology 2010 Congress (ESC) on August 29, 2010 in Stockholm. Professor Dr. Uta Hoppe of...

2010-06-15 16:05:27

Transcatheter valve-in-valve implantation provides option for high-risk patients Doctors at the University Heart Center in Hamburg, Germany successfully used transcatheter valve-in-valve implantation in elderly patients with degenerated bioprostheses in aortic and mitral position. This minimally invasive procedure was used as an alternative treatment option for patients who were at high surgical risk. Full details of the study are available in the June issue of Catheterization and...

2010-04-13 07:07:00

WALTHAM, Mass., April 13 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the rigorous FDA approval process is creating major hurdles for percutaneous heart valve device manufacturers. Although percutaneous aortic valves and percutaneous mitral valves gained CE mark approval in Europe in 2007 and 2008, respectively, these devices are not expected to launch in the US market until 2011 and 2012. Percutaneous...

2010-03-22 05:30:00

MINNEAPOLIS, March 22 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced that Health Canada-Medical Device Bureau, Therapeutic Products Programme has approved commercialization of the ATS Simulus® Annuloplasty Product Line for valve repair. (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO) The Simulus product portfolio includes flexible,...

2010-03-14 07:05:00

ATLANTA, March 14 /PRNewswire-FirstCall/ -- Late-breaking data presented today at the American College of Cardiology's 59th annual scientific session from the landmark EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) trial demonstrated that Abbott's investigational MitraClip® system met both its primary safety and effectiveness endpoints(1), suggesting that the minimally invasive MitraClip procedure may be an important treatment option for patients with...

2010-03-14 07:00:00

EVANSTON, Ill., March 14 /PRNewswire/ -- NorthShore University HealthSystem (NorthShore) interventional cardiologist, Ted Feldman, MD, presented data today at the American College of Cardiology annual scientific sessions from the EVEREST II trial (Endovascular Valve Edge-to-Edge REpair STudy) demonstrating the MitraClip, a novel, first-in-class catheter-based device, is a safe and effective alternative to open heart surgery for select patients with mitral regurgitation. "This is a major...

2010-02-09 07:00:00

OR YEHUDA, Israel, Feb. 9 /PRNewswire/ -- Valtech Cardio Ltd. announced today that Bruce H. KenKnight, PhD has joined the Valtech team serving as President and Chief Executive Officer. This announcement comes on the heels of Valtech's recently announced Series B financing that totaled $17.8 million from new and existing investors (OXO Capital Valve Ventures, NGN Capital and Peregrine Ventures). Bruce has more than 25 years of experience in medical device research and development (R&D)...

2010-02-02 07:00:00

OR YEHUDA, Israel, Feb. 2 /PRNewswire/ -- Valtech Cardio Ltd. announced today that new and existing investors (OXO Capital Valve Ventures LLC, NGN Biomed Opportunity II, L.P., and Peregrine VC Investments II, L.P.) recently completed a Series B financing of $17.8 million. Valtech Cardio Ltd. (Valtech) is engaged in development of a portfolio of minimally-invasive surgical and transcatheter mitral valve repair and replacement technologies designed to correct or significantly improve mitral...

2009-11-02 07:00:00

ABBOTT PARK, Ill., Nov. 2 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today that it has completed its acquisition of Evalve, Inc., the global leader in the development of devices for minimally invasive repair of mitral valves. The acquisition provides Abbott with a leading presence in the growing area of non-surgical treatment for structural heart disease. Evalve's minimally invasive catheter-based MitraClip® system is the first commercially available...